Literature DB >> 2601698

The 216-nucleotide intron of the E1A pre-mRNA contains a hairpin structure that permits utilization of unusually distant branch acceptors.

K Chebli1, R Gattoni, P Schmitt, G Hildwein, J Stevenin.   

Abstract

A recently characterized 216-nucleotide intron-splicing reaction occurs within the adenovirus E1A pre-mRNA through the use of three branch acceptor sites, located at 59, 55, and 51 nucleotides from the 3' splice site. To investigate the role of the cis-acting sequence elements in the selection of such unusually distant branch sites, transcripts differing in sequence downstream of the branch sites were analyzed for in vitro splicing. Initial results suggested that secondary structure could be involved in the use of distant branch sites. The involvement of a hairpin structure, including a nine-G C-base-pair stem, was supported by the results of site-directed mutagenesis analyses. Mutations that destroyed or weakened this hairpin resulted in an inefficient splicing reaction. In contrast, complementary mutation or deletion of two bulges, which involved a restoration or reinforcement of the hairpin, resulted in a reactivation or improvement of the splicing efficiency, respectively. Therefore, we conclude that the hairpin structure shortens the operational distance between the 3' splice site and the branch acceptors and brings the branch sites into the branch-permissive window, 18 to 40 nucleotides upstream of the 3' splice site. Our results confirm the importance of the constraint of distance for the splicing reaction and show that this constraint may be overcome by means of a stable hairpin formation.

Mesh:

Substances:

Year:  1989        PMID: 2601698      PMCID: PMC363635          DOI: 10.1128/mcb.9.11.4852-4861.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Specific and stable intron-factor interactions are established early during in vitro pre-mRNA splicing.

Authors:  B Ruskin; M R Green
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

2.  The role of nucleotide sequences in splice site selection in eukaryotic pre-messenger RNA.

Authors:  L P Eperon; J P Estibeiro; I C Eperon
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

Review 3.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

4.  Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA.

Authors:  M Aebi; H Hornig; R A Padgett; J Reiser; C Weissmann
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

5.  Effect of mutations at the lariat branch acceptor site on beta-globin pre-mRNA splicing in vitro.

Authors:  H Hornig; M Aebi; C Weissmann
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

6.  Nonconsensus branch-site sequences in the in vitro splicing of transcripts of mutant rabbit beta-globin genes.

Authors:  R A Padgett; M M Konarska; M Aebi; H Hornig; C Weissmann; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Trans splicing of mRNA precursors.

Authors:  D Solnick
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

8.  Alternative splicing caused by RNA secondary structure.

Authors:  D Solnick
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

9.  UACUAAC is the preferred branch site for mammalian mRNA splicing.

Authors:  Y A Zhuang; A M Goldstein; A M Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Yeast pre-messenger RNA splicing efficiency depends on critical spacing requirements between the branch point and 3' splice site.

Authors:  A Cellini; E Felder; J J Rossi
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  37 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Multiple activities of the human splicing factor ASF.

Authors:  J E Harper; J L Manley
Journal:  Gene Expr       Date:  1992

4.  Sequences involved in the control of adenovirus L1 alternative RNA splicing.

Authors:  J P Kreivi; K Zerivitz; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 5.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

Review 6.  Influence of RNA secondary structure on the pre-mRNA splicing process.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Differential block of U small nuclear ribonucleoprotein particle interactions during in vitro splicing of adenovirus E1A transcripts containing abnormally short introns.

Authors:  M Himmelspach; R Gattoni; C Gerst; K Chebli; J Stévenin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  Identification of a specific exon sequence that is a major determinant in the selection between a natural and a cryptic 5' splice site.

Authors:  L Domenjoud; H Gallinaro; L Kister; S Meyer; M Jacob
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

Review 9.  Role of RNA structure in regulating pre-mRNA splicing.

Authors:  M Bryan Warf; J Andrew Berglund
Journal:  Trends Biochem Sci       Date:  2009-12-01       Impact factor: 13.807

10.  Splice site selection in polyomavirus late pre-mRNA processing.

Authors:  D B Batt; L M Rapp; G G Carmichael
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.